Microbiota profile in new-onset pediatric Crohn's disease: data from a non-Western population

Mohammad I El Mouzan1, Harland S Winter2, Assad A Assiri3

  • 11Pediatric IBD Research Group, Gastroenterology Division, Department of Pediatrics, King Saud University, P. O. Box 2925, Riyadh, 11461 Kingdom of Saudi Arabia.

Gut Pathogens
|December 7, 2018
PubMed

Insights

The gut microbiota in children with Crohn's disease (CD) in Saudi Arabia showed altered bacterial populations, with reduced diversity in stool. This suggests lifestyle changes may impact the microbiome in CD patients.

Area of Science:

  • Microbiome research
  • Pediatric gastroenterology
  • Inflammatory bowel disease

Background:

  • The gut microbiota's role in Crohn's disease (CD) is recognized, but data from non-Western populations are scarce.
  • Understanding population-specific variations is crucial for comprehensive CD research.

Purpose of the Study:

  • To characterize the gut microbiota profile in children diagnosed with Crohn's disease in Saudi Arabia.
  • To compare findings with existing literature from Western populations.

Main Methods:

  • Analysis of stool and mucosal samples from children with CD and healthy controls.
  • Assessment of microbial community composition and diversity (alpha and beta diversity).

Main Results:

  • Specific bacterial genera like Fusobacterium and Peptostreptococcus were more abundant in CD patients.
  • Genera such as Roseburia, Clostridium, and Lactobacillus were significantly depleted in children with CD.
  • Reduced alpha diversity was observed in stool samples, and beta diversity differed significantly between CD and control groups.

Conclusions:

  • The observed gut microbiota pattern in Saudi children with CD resembles that in Western populations.
  • Dietary and lifestyle changes may be influencing the gut microbiome structure in this population, contributing to CD pathogenesis.
Abstract

Related Concept Videos

Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...